Nava Health Md (NAVA) Stock Price, News & Analysis

Company Overview

Blox, Inc. engages in the acquisition and exploration of mineral properties. It is also involved in the development of mineral resources for mining with the intent of applying green innovation plus renewable energy, and technology to traditional mining methods. The firm focuses on the Ghana and Guinea mining projects. The company was founded on July 21, 2005 and is headquartered in New York, NY.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

NAVA Stock Analysis - Frequently Asked Questions

When did Nava Health Md IPO?

Nava Health Md (NAVA) raised $8 million in an IPO on Friday, March 10th 2023. The company issued 1,400,000 shares at a price of $6.00 per share. WestPark Capital served as the underwriter for the IPO.

What other stocks do shareholders of Nava Health Md own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Nava Health Md investors own include Manulife Financial (MFC), BlackBerry (BB) and Xiao-I (AIXI).

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Non-Energy Minerals
• Industry: Precious Metals
• Sub-Industry: N/A
• Current Symbol: NASDAQ:NAVA
• CUSIP: N/A
• CIK: 1932231
• Web: N/A
• Phone: (604) 314-9293
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A